BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
FACILITIES: Production facility comprises a fermentation development laboratory (10L
fermenters), a dedicated quality control laboratory, and a fully contained
processing plant (with medium preparation and continuous sterilization,
fermentation and downstream processing and aseptic packaging)
STOCK-FINANCIAL HISTORY: Privately held
PRIVATE PLACEMENTS: Raised EUR3.5M in private financing (2/05)
SUBSIDIARY OF: Unilever
BUSINESS STRATEGY: Development and manufacture of ligands for Affinity Separation applications
RESEARCH & DEVELOPMENT: CaptureSelect® products are based on the company's proprietary single
domain antibody fragments and efficiently produced in-house using
Saccharomyces cerevisiae
Expression systems and fermentation production systems
Industrial scale 15,000l for production of novel single-chain Llama antibody
fragments, peptides, fusion proteins
PRODUCTS ON MARKET: Products:
CaptureSelect® products possess a combination of unique properties such
as stability, affinity, and selectivity that provides competitive benefits in
terms of reduced cost of purification, higher quality product, and increased
flexibility in the purification process. BAC offers a wide range of
CaptureSelect® products for different applications:
-Life science research such as sample preparation and small scale
purification
-Biopharma manufacturing including monoclonal antibodies and viruses
-Healthcare applications such as therapeutic apheresis
-Custom tailored purification solutions
BACHEM AG
Services:
Custom manufacturing and upscaling of production of biotechnological
molecules through microbial fermentations
Plug-in of genes into yeasts, followed by process development and scale up
Hauptstrasse 144
Bubendorf CH-4416, Switzerland
Phone: +41 61 935 2323; Fax: +41 61 935 2325
Web: www.bachem.com
E-mail: sales.ch@bachem.com
KEY PERSONNEL: Dr. Peter Grogg; Chairman
Rolf Nyfeler, Ph.D.;CEO
Michael Husler; CFO
Dr. Daniel Erne; CTO
Thomas Fruh, Ph.D; Exec. VP and COO, BACHEM AG
Jose de Chastonay, Ph.D.; President, BACHEM Americas
Philip Ottiger; President and COO, Bachem California Inc.
Dr. Mike Pennington; President and COO, Bachem Bioscience Inc.
Dr. Damir Vidovic; President and COO, Peninsula Laboratories Inc.
Dr. Stanley Moore; COO, Bachem (UK) Ltd.
Dr. Jacques-Alain Cotting; COO, Sochinaz SA
EMPLOYEES: 540 employees
HISTORY: Founded in 1971
Founded BACHEM Bioscience in Philadelphia, Pa. (1987)
Founded BACHEM Biochemica in Heidelberg, Germany (1988)
Founded BACHEM Biochimie in Voisins-le-Bretonneux, France (1993)
Acquired BACHEM California Inc in Torrance, Calif., and its U.K. subsidiary
in Saffron Walden (1996)
Copyright ©2006 AHC Media ® 55